Detalhe da pesquisa
1.
Distinct induction pathways of heat shock protein 27 in human keratinocytes: Heat stimulation or capsaicin through phosphorylation of heat shock factor 1 at serine 326 and/or suppression of ΔNp63.
Biochem Biophys Res Commun
; 708: 149817, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537528
2.
Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes.
J Pathol
; 260(3): 304-316, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37138382
3.
Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases.
J Clin Immunol
; 43(2): 466-478, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336768
4.
Difference in immunohistochemical findings among anti-PD-L1 antibodies and their relationships with CD4+ and CD8+ T cells in Japanese melanoma patients.
Int J Clin Oncol
; 27(8): 1364-1371, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35650364
5.
Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review.
Int J Mol Sci
; 23(12)2022 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35742905
6.
Immunotherapy for advanced melanoma: current situation in Japan.
Jpn J Clin Oncol
; 51(1): 3-9, 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140101
7.
Regular sweating activities for the treatment of cholinergic urticaria with or without acquired idiopathic generalized anhidrosis.
Dermatol Ther
; 33(4): e13647, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32445244
8.
Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma.
Int J Mol Sci
; 21(17)2020 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32854423
9.
Significance of 5-S-Cysteinyldopa as a Marker for Melanoma.
Int J Mol Sci
; 21(2)2020 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31936623
10.
Long-term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma.
Cancer Sci
; 110(6): 1995-2003, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959557
11.
Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan.
Int J Clin Oncol
; 24(12): 1508-1514, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470725
12.
[Melanoma and Non-Melanoma Skin Cancers].
Gan To Kagaku Ryoho
; 51(4): 392, 2024 Apr.
Artigo
em Japonês
| MEDLINE | ID: mdl-38644303
13.
[Efficacy and Management of Adverse Events of Ipilimumab Including Combination Therapy with Nivolumab].
Gan To Kagaku Ryoho
; 46(6): 1017-1026, 2019 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-31273168
14.
Bacillus Calmette-Guérin-induced lupus vulgaris in a patient with Mendelian susceptibility to mycobacterial disease caused by a novel STAT1 variation.
Br J Dermatol
; 188(1): 142-143, 2023 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689501
15.
Evaluation of degeneration of excision margin tissue using a Colorado MicroDissection Needle: A report of two cases.
Australas J Dermatol
; 64(3): e301-e303, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052243
16.
[Melanoma and Non-Melanoma Skin Cancers Evolution of Systemic Therapy for Skin Cancer].
Gan To Kagaku Ryoho
; 50(4): 451, 2023 04.
Artigo
em Japonês
| MEDLINE | ID: mdl-37066454
17.
Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study.
Cancer Sci
; 108(6): 1223-1230, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28342215
18.
Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma.
Cancer Sci
; 108(5): 1022-1031, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28266140
19.
Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective study.
Br J Dermatol
; 187(4): 594-596, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347707
20.
Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients.
Acta Derm Venereol
; 97(10): 1212-1218, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28681063